Jessica Shaw
Family · Fort Worth, TXNPI 1417969429
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.5% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $846 and has fallen 51.8% since, to $408 in 2025.
Across 40 payments — averaging $50.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$424
- AbbVie$269
- Regeneron Healthcare Solutions, Inc.$251
- E.r. Squibb & Sons, L.L.C.$234
- Sirtex Medical Inc$146
- Johnson & Johnson$140
- plus $547 from 8 others
What the payments were for
- Food & beverage$1,92196%
- Education$904%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead(2 entities) | 8 | $424 |
| AbbVie | 4 | $269 |
| Regeneron Healthcare Solutions, Inc. | 16 | $251 |
| E.r. Squibb & Sons, L.L.C. | 2 | $234 |
| Sirtex Medical Inc | 1 | $146 |
| Johnson & Johnson | 1 | $140 |
| Monteris Medical Corporation | 1 | $135 |
| Pharmacosmos Therapeutics Inc. | 1 | $121 |
| Stemline Therapeutics Inc. | 1 | $120 |
| Bard Peripheral Vascular, Inc. | 1 | $73 |
| Astellas Pharma US Inc | 1 | $31 |
| Molnlycke Health Care US, LLC | 1 | $28 |
| W. L. Gore & Associates, Inc. | 1 | $26 |
| Bristol Myers Squibb | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Yescarta$241
- Reblozyl$234
- SIR-Spheres Microspheres$146
- TALVEY$140
- TECVAYLI$140
- CARVYKTI$140
- Neuroblate$135
- EPKINLY$125
- Monoferric$121
- Orserdu$120
- Trodelvy$111
How this compares
$2,011 in reported general payments places this provider in the 80th percentile of 15,456 family providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Fort Worth
- Laura MoeFort Worth$158K
- Julie TaylorFort Worth$63K
- Ryan BourgeoisFort Worth$37K
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.